120 related articles for article (PubMed ID: 35193833)
21. Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study.
De Nunzio C; Simone G; Brassetti A; Mastroianni R; Collura D; Muto G; Gallucci M; Tubaro A
BMC Cancer; 2016 Jul; 16():407. PubMed ID: 27386844
[TBL] [Abstract][Full Text] [Related]
22. Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer.
Ong WL; Foroudi F; Evans S; Millar J
BJU Int; 2017 Nov; 120 Suppl 3():35-42. PubMed ID: 28749017
[TBL] [Abstract][Full Text] [Related]
23. Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category.
Jochems SHJ; Stattin P; Häggström C; Järvholm B; Orho-Melander M; Wood AM; Stocks T
Int J Cancer; 2020 Dec; 147(12):3328-3338. PubMed ID: 32525555
[TBL] [Abstract][Full Text] [Related]
24. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
Gong Z; Neuhouser ML; Goodman PJ; Albanes D; Chi C; Hsing AW; Lippman SM; Platz EA; Pollak MN; Thompson IM; Kristal AR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1977-83. PubMed ID: 17035408
[TBL] [Abstract][Full Text] [Related]
25. Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy.
Hong SK; Oh JJ; Byun SS; Hwang SI; Lee HJ; Choe G; Lee SE
Prostate; 2012 Jan; 72(1):51-7. PubMed ID: 21520162
[TBL] [Abstract][Full Text] [Related]
26. A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk.
Wallström P; Bjartell A; Gullberg B; Olsson H; Wirfält E
Br J Cancer; 2009 Jun; 100(11):1799-805. PubMed ID: 19436298
[TBL] [Abstract][Full Text] [Related]
27. The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy.
Nocera L; Wenzel M; Collà Ruvolo C; Würnschimmel C; Tian Z; Gandaglia G; Fossati N; Chun FKH; Mirone V; Graefen M; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
World J Urol; 2022 Jan; 40(1):103-110. PubMed ID: 34436637
[TBL] [Abstract][Full Text] [Related]
28. Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy.
Yu YD; Byun SS; Lee SE; Hong SK
Sci Rep; 2018 Aug; 8(1):11962. PubMed ID: 30097640
[TBL] [Abstract][Full Text] [Related]
29. Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients.
Schiffmann J; Karakiewicz PI; Rink M; Manka L; Salomon G; Tilki D; Budäus L; Pompe R; Leyh-Bannurah SR; Haese A; Hammerer P; Huland H; Graefen M; Tennstedt P
World J Urol; 2018 Jul; 36(7):1067-1072. PubMed ID: 29497861
[TBL] [Abstract][Full Text] [Related]
30. Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection.
Tafuri A; Amigoni N; Rizzetto R; Sebben M; Shakir A; Gozzo A; Odorizzi K; De Michele M; Gallina S; Bianchi A; Ornaghi P; Brunelli M; De Marco V; Verratti V; Migliorini F; Cerruto MA; Artibani W; Antonelli A; Porcaro AB
Int Urol Nephrol; 2020 Nov; 52(11):2097-2105. PubMed ID: 32607958
[TBL] [Abstract][Full Text] [Related]
31. Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies.
Parker AS; Thiel DD; Bergstralh E; Carlson RE; Rangel LJ; Joseph RW; Diehl N; Karnes RJ
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):352-6. PubMed ID: 23958895
[TBL] [Abstract][Full Text] [Related]
32. Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.
Ferro M; Terracciano D; Musi G; de Cobelli O; Vartolomei MD; Damiano R; Cantiello F; Buonerba C; Morelli M; Mistretta FA; Luzzago S; Perdonà S; Del Prete P; Del Giudice F; Busetto GM; Porreca A; Autorino R; Manfredi M; Porpiglia F; Muto M; Loizzo D; Ditonno P; Battaglia M; Lucarelli G
Urol Int; 2022; 106(1):75-82. PubMed ID: 34167120
[TBL] [Abstract][Full Text] [Related]
33. Larger men have larger prostates: Detection bias in epidemiologic studies of obesity and prostate cancer risk.
Rundle A; Wang Y; Sadasivan S; Chitale DA; Gupta NS; Tang D; Rybicki BA
Prostate; 2017 Jun; 77(9):949-954. PubMed ID: 28349547
[TBL] [Abstract][Full Text] [Related]
34. Association of body mass index and prostate cancer mortality.
Haque R; Van Den Eeden SK; Wallner LP; Richert-Boe K; Kallakury B; Wang R; Weinmann S
Obes Res Clin Pract; 2014; 8(4):e374-81. PubMed ID: 25091359
[TBL] [Abstract][Full Text] [Related]
35. Robotic-assisted laparoscopic prostatectomy in men with metabolic syndrome.
Kwon YS; Leapman M; McBride RB; Hobbs AR; Collingwood SA; Stensland KD; Samadi DB
Urol Oncol; 2014 Jan; 32(1):40.e9-16. PubMed ID: 23820091
[TBL] [Abstract][Full Text] [Related]
36. Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
Freedland SJ; Branche BL; Howard LE; Hamilton RJ; Aronson WJ; Terris MK; Cooperberg MR; Amling CL; Kane CJ;
BJU Int; 2019 Jul; 124(1):69-75. PubMed ID: 30347135
[TBL] [Abstract][Full Text] [Related]
37. Improving the Stratification of Patients With Intermediate-risk Prostate Cancer.
Stolzenbach LF; Nocera L; Collà-Ruvolo C; Tian Z; Knipper S; Maurer T; Tilki D; Graefen M; Karakiewicz PI
Clin Genitourin Cancer; 2021 Apr; 19(2):e120-e128. PubMed ID: 33358891
[TBL] [Abstract][Full Text] [Related]
38. Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: results from the North-American case-control study Prostate Cancer & Environment Study.
Boehm K; Sun M; Larcher A; Blanc-Lapierre A; Schiffmann J; Graefen M; Sosa J; Saad F; Parent MÉ; Karakiewicz PI
Urol Oncol; 2015 Nov; 33(11):494.e1-7. PubMed ID: 26278366
[TBL] [Abstract][Full Text] [Related]
39. Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy.
Goris Gbenou MC; Peltier A; Schulman CC; Velthoven Rv
Urol Oncol; 2016 Jun; 34(6):254.e1-6. PubMed ID: 26822075
[TBL] [Abstract][Full Text] [Related]
40. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
Bassett WW; Cooperberg MR; Sadetsky N; Silva S; DuChane J; Pasta DJ; Chan JM; Anast JW; Carroll PR; Kane CJ
Urology; 2005 Nov; 66(5):1060-5. PubMed ID: 16286124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
